Recent Posts

A new immunotherapeutic agent for children and adolescents with advanced lymphoma

It establishes a new standard treatment with an improved cure rate for children with advanced non-Hodgkin lymphoma, mainly Burkitt lymphoma.

Read more: https://www.eurekalert.org/pub_releases/2020-06/cccg-ani060320.php